These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

824 related items for PubMed ID: 18288745

  • 1. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C, Timmermanns I, Reissmann U, van Essen J, Schräder R.
    Catheter Cardiovasc Interv; 2008 Feb 15; 71(3):390-5. PubMed ID: 18288745
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
    Silvestry FE, Naseer N, Wiegers SE, Hirshfeld JW, Herrmann HC.
    Catheter Cardiovasc Interv; 2008 Feb 15; 71(3):383-7. PubMed ID: 18288733
    [Abstract] [Full Text] [Related]

  • 3. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T, Petzsch M, Ince H, Rehders TC, Körber T, Weber F, Schneider H, Auf der Maur C, Nienaber CA.
    J Interv Cardiol; 2005 Jun 15; 18(3):173-9. PubMed ID: 15966921
    [Abstract] [Full Text] [Related]

  • 4. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG, Post MC, Schräder R, Sluysmans T, Vydt T, Vermeersch P, Chessa M, Onorato E, Goy JJ, Budts WI.
    Catheter Cardiovasc Interv; 2008 May 01; 71(6):822-8. PubMed ID: 18324695
    [Abstract] [Full Text] [Related]

  • 5. Comparison of contemporary devices used for transcatheter patent foramen ovale closure.
    Spies C, Reissmann U, Timmermanns I, Schräder R.
    J Invasive Cardiol; 2008 Sep 01; 20(9):442-7. PubMed ID: 18762672
    [Abstract] [Full Text] [Related]

  • 6. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder.
    Spies C, Strasheim R, Timmermanns I, Schraeder R.
    Eur Heart J; 2006 Feb 01; 27(3):365-71. PubMed ID: 16254007
    [Abstract] [Full Text] [Related]

  • 7. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial.
    Zhang CJ, Huang YG, Huang XS, Huang T, Huang WH, Shen JJ, Xun ZR.
    Chin Med J (Engl); 2010 Apr 05; 123(7):834-7. PubMed ID: 20497673
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
    Ewert P, Söderberg B, Dähnert I, Hess O, Schuler G, Bussmann C, Bernhard J, Sick P.
    Catheter Cardiovasc Interv; 2008 Feb 15; 71(3):398-402. PubMed ID: 18288739
    [Abstract] [Full Text] [Related]

  • 11. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.
    Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, Haass M, Schraeder R, Strasser RH.
    Eur Heart J; 2004 Mar 15; 25(5):424-30. PubMed ID: 15033255
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M, Casalino L, Gnecco G, Bezante GP, Pongiglione G, Marasini M, Del Sette M, Barsotti A.
    Am Heart J; 2008 Aug 15; 156(2):356-60. PubMed ID: 18657668
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
    Hong TE, Thaler D, Brorson J, Heitschmidt M, Hijazi ZM, Amplatzer PFO Investigators.
    Catheter Cardiovasc Interv; 2003 Dec 15; 60(4):524-8. PubMed ID: 14624434
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. New onset atrial fibrillation after patent foramen ovale closure.
    Staubach S, Steinberg DH, Zimmermann W, Wawra N, Wilson N, Wunderlich N, Sievert H.
    Catheter Cardiovasc Interv; 2009 Nov 15; 74(6):889-95. PubMed ID: 19626689
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism.
    Spies C, Khandelwal A, Timmemanns I, Kavinsky CJ, Schräder R, Hijazi ZM.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):966-70. PubMed ID: 18942060
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.